Use of disease-associated gene
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 23, 2004
app pub date -
Dec 31, 2003
filing date -
Jul 4, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention has an object to provide a method of screening a compound capable of inhibiting the activities of the disease-associated gene product, compounds obtainable by the screening method, etc. The compounds or a salt thereof that inhibits the activity of the protein having an amino acid sequence identical or substantially identical with the amino acid sequence represented by SEQ ID NO: 1, or a neutralizing antibody that inhibits the activity of that protein may be used as a prophylactic and/or therapeutic agent for various diseases, for example, pulmonary/thoracic diseases and respiratory diseases accompanied by pulmonary/airway inflammation [e.g. chronic obstructive pulmonary diseases (such as chronic bronchitis, pulmonary emphysema, diffuse panbronchiolitis, intrinsic asthma), bronchial asthma, cystis fibrosis, hypersensitivity pneumonitis, pulmonary fibrosis, etc.], inflammatory bowel diseases, allergic conjunctivitis, and so on.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully